Jacob Van Naarden Eli Lilly & CO (LLY) insider trading activity

Jacob Van Naarden is EVP & Pres., Lilly Oncology of ELI LILLY & Co. Currently has a direct ownership of 20,561 shares of LLY, which is worth approximately $16.9 Million. The most recent transaction as insider was on Aug 13, 2025, when has been sold 1,000 shares (Common Stock) at a price of $647.36 per share, resulting in proceeds of $647,360. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.6K

5.11% 3M change

27.34% 12M change

Total Value Held $16.9 Million

Jacob Van Naarden Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 13 2025	BUY Open market or private purchase	$647,360 $647.36 p/Share	1,000 Added 4.64%	20,561 Common Stock
Feb 10 2025	BUY Grant, award, or other acquisition	$5,302,774 $868.88 p/Share	6,103 Added 23.78%	19,561 Common Stock
Feb 01 2025	SELL Payment of exercise price or tax liability	$1,142,811 $811.08 p/Share	1,409 Reduced 9.48%	13,458 Common Stock
Feb 01 2025	BUY Exercise of conversion of derivative security	-	3,023 Added 16.9%	14,868 Common Stock
Oct 31 2024	SELL Bona fide gift	-	4,302 Reduced 26.64%	11,845 Common Stock
Feb 12 2024	BUY Grant, award, or other acquisition	$1,746,568 $737.26 p/Share	2,369 Added 12.79%	16,147 Common Stock
Feb 01 2024	SELL Payment of exercise price or tax liability	$1,087,852 $645.61 p/Share	1,685 Reduced 10.9%	13,778 Common Stock
Feb 01 2024	BUY Exercise of conversion of derivative security	-	3,618 Added 18.96%	15,463 Common Stock
Feb 16 2023	SELL Payment of exercise price or tax liability	$440,203 $335.01 p/Share	1,314 Reduced 9.99%	11,845 Common Stock
Feb 16 2023	BUY Exercise of conversion of derivative security	-	2,785 Added 17.47%	13,159 Common Stock
Feb 10 2023	BUY Grant, award, or other acquisition	$830,703 $345.12 p/Share	2,407 Added 18.83%	10,374 Common Stock
Feb 16 2022	SELL Payment of exercise price or tax liability	$533,034 $243.84 p/Share	2,186 Reduced 21.53%	7,967 Common Stock
Feb 16 2022	BUY Exercise of conversion of derivative security	-	5,461 Added 34.98%	10,153 Common Stock

JVN

Jacob Van Naarden

EVP & Pres., Lilly Oncology

Indianapolis, IN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LLY shares.

Notify only if

Value

Insider Trading

Get notified when an Eli Lilly & CO insider buys or sells LLY shares.

Notify only if

Operation

Value

Type

News

Receive news related to ELI LILLY & Co

Track Activities on LLY

Account